These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1380 related articles for article (PubMed ID: 19735864)

  • 21. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy.
    Hallemeier CL; Botros M; Corsini MM; Haddock MG; Gunderson LL; Miller RC
    Am J Clin Oncol; 2011 Dec; 34(6):567-72. PubMed ID: 21150564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
    Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
    Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.
    Leong CN; Chung HT; Lee KM; Shakespeare TP; Mukherjee RK; Wong LC; Lu JJ; Tey J; Lim R; So JB; Back MF
    Cancer J; 2008; 14(4):269-75. PubMed ID: 18677137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
    J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
    White RR; Xie HB; Gottfried MR; Czito BG; Hurwitz HI; Morse MA; Blobe GC; Paulson EK; Baillie J; Branch MS; Jowell PS; Clary BM; Pappas TN; Tyler DS
    Ann Surg Oncol; 2005 Mar; 12(3):214-21. PubMed ID: 15827813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
    Huguet F; André T; Hammel P; Artru P; Balosso J; Selle F; Deniaud-Alexandre E; Ruszniewski P; Touboul E; Labianca R; de Gramont A; Louvet C
    J Clin Oncol; 2007 Jan; 25(3):326-31. PubMed ID: 17235048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1186-90. PubMed ID: 19962835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
    McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
    Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma.
    Lavaf A; Genden EM; Cesaretti JA; Packer S; Kao J
    Cancer; 2008 Feb; 112(3):535-43. PubMed ID: 18076014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
    Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
    Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
    Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW;
    N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant therapy for resected gastric cancer--rapid, yet incomplete adoption following results of intergroup 0116 trial.
    Coburn NG; Guller U; Baxter NN; Kiss A; Ringash J; Swallow CJ; Law CH
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1073-80. PubMed ID: 17905529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.
    Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
    Cancer; 2010 Jun; 116(12):2932-40. PubMed ID: 20336787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
    Collette L; Bosset JF; den Dulk M; Nguyen F; Mineur L; Maingon P; Radosevic-Jelic L; Piérart M; Calais G;
    J Clin Oncol; 2007 Oct; 25(28):4379-86. PubMed ID: 17906203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of adjuvant therapy for pancreatic cancer.
    Takeda S; Inoue S; Kaneko T; Harada A; Nakao A
    Hepatogastroenterology; 2001; 48(40):953-6. PubMed ID: 11490847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients.
    Kuhlmann KF; de Castro SM; Wesseling JG; ten Kate FJ; Offerhaus GJ; Busch OR; van Gulik TM; Obertop H; Gouma DJ
    Eur J Cancer; 2004 Mar; 40(4):549-58. PubMed ID: 14962722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
    Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
    Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.